CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Green Cross Holdings is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Green Cross Holdings
107, Ihyeon-ro 30beon-gil, Giheung-gu
Phone: +82 312609300p:+82 312609300 YONGIN, 16924  South Korea Ticker: 005250005250
Business Summary
Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Manufacturing and Sale segment mainly manufactures and sells blood products, general pharmaceuticals, vaccines and over-the-counter (OTC) drugs. The Medical Service and System Development and Supply segment primarily provides healthcare services. The Diagnostic and Analysis segment mainly engages in blood diagnostics and genetic analysis business. The Leasing and Service Business segment is primarily involved in the real estate leasing and the management of affiliated group companies. The Other segment mainly operates livestock operation and other business.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2835 In vitro and in vivo diagnostic substances
8731 Commercial physical and biological research
2836 Biological products, except diagnostic substances
7373 Computer integrated systems design
6513 Operators of apartment buildings
6531 Real estate agents and managers
6719 Offices of holding companies, not elsewhere classified
0279 Animal specialties, not elsewhere classified
6726 Unit investment trusts, face-amount certificate offices
2833 Medicinal chemicals and botanical products
5999 Miscellaneous retail stores, not elsewhere classified
6512 Operators of nonresidential buildings
5122 Drugs, drug proprietaries, and druggists' sundries
2095 Roasted coffee
6282 Investment advice
8742 Management consulting services
7372 Prepackaged software
0252 Chicken eggs
5099 Durable goods, not elsewhere classified
7375 Information retrieval services
1541 General contractors-industrial buildings and warehouses
7389 Business services, not elsewhere classified
8732 Commercial economic, sociological, and educational research
8711 Engineering services

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman, Co-Chief Executive Officer Yil SeopHuh 71 3/24/2017
Co-Chief Executive Officer, Director Yong JunHuh 51 3/24/2017 3/12/2010
Vice Chairman Yong TaePark 75 1/1/2010 3/13/2009
3 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Made Scientific 138 Summit Street Newark NJ United States

Business Names
Business Name
005250
005255
005257
5 additional Business Names available in full report.

General Information
Number of Employees: 170 (As of 12/31/2015)
Outstanding Shares: 45,441,076 (As of 12/31/2025)
Shareholders: 26,225
Stock Exchange: KRX
Fax Number: +82 312609405


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, May 13, 2026